# Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial (NEXT Trial)

Study · id `cardio:ct-nct06693011` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06693011](<https://clinicaltrials.gov/study/NCT06693011>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06693011

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 250 participants.

## Technical summary

Registry record NCT06693011. Allocation not applicable; no masking; primary purpose treatment. Start 2025-06-10 (actual); primary completion 2028-10 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 250 participants (planned count; ClinicalTrials.gov record NCT06693011, source copy `cardio:ctgov-nct06693011-2026-03-31`, retrieved 2026-11-18)
- Started: 2025-06-10 (actual) (ClinicalTrials.gov record NCT06693011, source copy `cardio:ctgov-nct06693011-2026-03-31`, retrieved 2026-11-18)
- Primary completion: 2028-10 (anticipated) (ClinicalTrials.gov record NCT06693011, source copy `cardio:ctgov-nct06693011-2026-03-31`, retrieved 2026-11-18)
- Completion: 2030-01 (anticipated) (ClinicalTrials.gov record NCT06693011, source copy `cardio:ctgov-nct06693011-2026-03-31`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT06693011, source copy `cardio:ctgov-nct06693011-2026-03-31`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06693011-2026-03-31`, retrieved 2026-11-18)

## The registry's words

- Brief title: Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial (NEXT Trial)
- Acronym: NEXT
- Condition: Cerebral Aneurysms
- Intervention (Device): Contour Neurovascular System Treatment Attempt
- Lead sponsor: Cerus Endovascular, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Brain aneurysm (intracranial aneurysm) (`cardio:intracranial-aneurysm`)

## Provenance

Content hash: 6fe64d84df7e1f654f105633460f1c56a8bef75e97d29c60c3e4eeb552735926
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
